Researchers have identified specific circular RNA (circRNA) and messenger RNA (mRNA) expression signatures across distinct lesion types in secondary progressive multiple sclerosis (SPMS), offering new insights into the molecular drivers of this neurodegenerative stage. This transcriptomic study, which utilized bioinformatics-based analysis of publicly available post-mortem brain tissue RNA-sequencing data, characterizes how these stable, covalently closed RNA molecules participate in complex regulatory networks during the chronic phases of multiple sclerosis. The study aimed to decode the molecular landscape within normal-appearing white matter (NAWM) and various lesion types, including active (AL), chronic active (CA), and inactive (IL) lesions. By investigating the systemic dysregulation of circRNAs, the authors sought to uncover candidate regulatory axes that drive MS pathogenesis, including inflammatory responses, axonal demyelination, and impaired repair mechanisms. The results demonstrate that circRNA-associated networks exhibit highly lesion-specific expression patterns and structural diversity, providing a critical resource for understanding the molecular progression of the disease and identifying potential candidate targets for future diagnostic and therapeutic interventions.
Multiple sclerosis is an inflammatory and neurodegenerative disease characterized by the breakdown of myelin, the protective coating of nerve fibers, leading to disrupted signal transmission within the central nervous system. As the disease advances from the initial relapsing-remitting phase into SPMS, patients experience an accumulation of diverse lesion types within the brain’s white matter. These lesions represent various pathological stages, ranging from early active inflammatory areas to chronic, smoldering plaques that exhibit gradual tissue destruction and failure of myelin repair. Normal-appearing white matter in these patients often shows subtle signs of pathology, including microglial activation and blood-brain barrier leakage, which precede the formation of more severe lesions. Understanding the biological drivers that control the transition to these progressive states remains a central challenge in MS research, particularly as traditional studies focused primarily on mRNA expression have often overlooked the regulatory potential of more stable RNA species.
Circular RNAs represent a unique class of endogenous, non-coding RNA molecules formed through back-splicing events, where a downstream splice donor ligates to an upstream splice acceptor. They are known to be enriched in brain tissue and function as regulators of gene expression, often acting as competing endogenous RNAs (ceRNAs) by sponging microRNAs (miRNAs) and sequestering RNA-binding proteins. When circRNAs bind to these miRNAs, they effectively rescue the miRNA-target mRNAs from repression, thereby modulating complex cellular pathways. The researchers leveraged these properties to hypothesize that circRNA dysregulation might be fundamental to the synaptic pathology, epigenetic changes, and immune system alterations observed in the brain tissue of patients with secondary progressive multiple sclerosis.
The study methodology involved a comprehensive re-analysis of RNA-sequencing data obtained from the UK Multiple Sclerosis Society Tissue Bank, including samples of NAWM, AL, IL, CA, and control white matter tissue from non-MS donors. Following rigorous quality checks and filtration steps—which included trimming low-quality reads and aligning the sequences against the human reference genome—the researchers selected 17 NAWM, six AL, eight IL, 13 CA, and 23 control paired-end samples for downstream processing. Two parallel analytical pipelines were employed to ensure the robust identification of circRNAs: CIRCexplorer2, which parses junction reads from chimeric alignments, and CIRI2, which identifies circularisation events through BWA alignment. Common circRNAs identified by both pipelines were then utilized for differential expression analysis. Linear transcripts were quantified using established pipelines to generate a gene count matrix, allowing the researchers to compare the relative expression levels of both circRNAs and mRNAs across the different lesion types relative to control tissue.
Differential expression analysis revealed distinct, lesion-dependent patterns of both circRNAs and linear transcripts, with active lesions showing the most extensive transcriptional shifts compared to other lesion types. While NAWM and CA lesions displayed more similar circRNA expression profiles, the active lesions were characterized by a prominent cluster of down-regulated circRNAs and a smaller population of up-regulated transcripts, reflecting a high level of inflammatory activity and massive cellular disruption. Overall, the researchers observed a consistent pattern of down-regulation in circRNA expression across disease samples compared to controls, a finding that aligns with previous investigations into MS transcriptomics. This pervasive down-regulation may be partially attributed to the ongoing smoldering inflammation and immune activity within the lesions, which contribute to chronic cell death and tissue degradation. Hierarchical clustering of these expression patterns confirmed that the active lesion stage exhibits a distinct transcriptional identity, marking it as a critical period of intense pathological change within the SPMS brain.
Functional enrichment analysis of the host genes associated with the differentially expressed circRNAs provided key insights into the biological processes involved in lesion progression. In active lesions, down-regulated circRNAs were significantly associated with neuronal regulation, synaptic signaling and structure, and cytoskeletal maintenance, highlighting the widespread synaptic loss and neuroinflammation that define this stage. KEGG pathway analysis further reinforced these findings, identifying pathways involved in autophagic dysregulation, where intracellular signaling systems and protein maintenance are severely impaired. Conversely, up-regulated circRNAs were found to be enriched in chromatin organization, epigenetic regulation, and various phosphorylation cascades. Specifically, pathways related to the ISWI ATP-dependent chromatin remodeling complex were identified as potentially playing a role in oligodendrocyte precursor cell differentiation. These findings suggest a cascading series of reactions in which synaptic dysfunction, structural instability, and epigenetic changes collectively drive the progression of the disease.
To further explore the regulatory potential of these molecules, the research team constructed circRNA-miRNA-mRNA networks, identifying key regulatory axes that could control MS-associated biological processes. Among the significant networks predicted were the circQSER1-hsa-miR-6891-5p/hsa-miR-6758-5p-SCD axis and the circFMN2-hsa-miR-4728-5p-SCD axis, both of which were found to be down-regulated in the active lesion type. Furthermore, the circCCDC7/hsa-miR-4659b-3p/HBEGF network was identified as down-regulated in chronic active lesions. The researchers assessed the white matter-specific expression of these miRNAs using the miRNATissueAtlas 2025, confirming that these miRNA loci are transcriptionally active in the relevant brain tissue compartments. These computational findings offer a novel perspective on how circRNAs might act as master regulators within the ceRNA network, potentially controlling the expression of key downstream proteins involved in MS pathogenesis and providing candidate regulatory nodes for further experimental validation.
The validation of these findings through independent GEO datasets—GSE255290 and GSE224377—demonstrated the robustness of these hub genes. For example, SCD expression showed strong diagnostic performance with an area under the curve (AUC) of up to 1.0 in validation cohorts, indicating a statistically significant correlation with MS pathology. The down-regulation of HBEGF in chronic active lesions is particularly notable, given its role in promoting the recruitment, proliferation, and migration of oligodendrocyte precursor cells to demyelinated sites. This study provides strong evidence that these hub genes, potentially under the control of circRNA-miRNA axes, are centrally involved in the protective and repair mechanisms that fail as lesions transition to the chronic progressive state.
The study also utilized advanced visualization techniques to analyze the structural diversity of the identified circRNAs, showing robust back-splice junction signals that confirm active transcription at these loci. Isoform profiling for circQSER1, circFMN2, and circCCDC7 revealed extensive circularization events and splicing diversity across the lesion types. For instance, the notable number of circCCDC7 isoforms in chronic active lesions suggests that alternative circularization may be a significant, yet previously under-appreciated, layer of post-transcriptional control. The presence of these isoforms, supported by multiple junction-spanning reads in the RNA-seq data, reinforces the biological reality of these circRNAs rather than dismissing them as splicing artifacts. However, the researchers noted that the diversity of these isoforms could be influenced by variations in read depth between different sample groups, necessitating further experimental confirmation to fully understand the functional consequences of specific back-splicing events in the context of MS lesion pathology.
While this research provides a comprehensive transcriptome-wide resource, the authors acknowledge several limitations inherent in the analysis of bulk RNA-seq data from human post-mortem tissues. Because bulk sequencing captures the average transcript abundance across a heterogeneous cell population—including oligodendrocytes, astrocytes, microglia, neurons, and infiltrating immune cells—it is impossible to assign these circRNA expression patterns to specific cell types using this approach alone. Furthermore, the limited sample size in some lesion categories, combined with the stringent quality filtration required to ensure reliability, may affect the statistical power of the results. The study highlights the need for future research that integrates single-cell or single-nucleus RNA sequencing, which would allow for the disentanglement of cell-intrinsic regulatory changes from overall tissue composition effects. Additionally, while the circRNA-miRNA-mRNA networks are supported by bioinformatic predictions, functional experimental validation, such as knockdown or overexpression studies and quantitative real-time PCR, remains essential to definitively establish the biological relevance of these regulatory axes in MS.
Ultimately, the comprehensive transcriptomic profiling conducted in this study establishes a foundation for future functional investigations into the role of circular RNAs in secondary progressive multiple sclerosis. By identifying lesion-specific regulatory networks and key hub genes such as SCD and HBEGF, the researchers have uncovered a new layer of molecular complexity that accompanies the progression of the disease. This resource potentially offers actionable insights for identifying diagnostic biomarkers and therapeutic targets that address the persistent inflammation and failure of repair characteristic of the chronic progressive phase of MS. Moving forward, the integration of multi-omics approaches and larger independent cohorts will be necessary to translate these bioinformatic findings into clinical applications, helping to clarify the cascade of reactions that drive MS pathology and opening new avenues for managing this debilitating neurodegenerative condition.
Subject of Research: Transcriptomic analysis of circular RNA dysregulation across multiple sclerosis lesion types.
Article Title: Lesion-specific circular RNA and mRNA signatures in secondary progressive multiple sclerosis
Article References: Gao, Y., Takenaka, K., Santucci, K., Lindner, G., Cheng, Y., Xu, S.-M., & Janitz, M. (2026). Lesion-specific circular RNA and mRNA signatures in secondary progressive multiple sclerosis. Molecular Brain, 19(1), Article 71. https://doi.org/10.1186/s13041-026-01333-y
Image Credits: AI Generated
DOI: 10.1186/s13041-026-01333-y
Keywords: Secondary Progressive Multiple Sclerosis, Circular RNA, mRNA, Transcriptomics, Bioinformatics, Neurodegeneration, RNA-seq, Biomarkers, Gene Expression, Central Nervous System, Inflammation, Demyelination, Regulatory Networks, Hub Genes, SCD, HBEGF, Synaptic Signaling, Epigenetics, Myelin Repair
News Source: Juliet Wilcox. (November 18, 2026). Circular RNA Signatures Map Secondary Progressive Multiple Sclerosis Lesion Pathology. Scienmag.



